ANAB
AnaptysBio Inc
51.00$
-1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +171.4% | -20.3% | +52.8% | +173.6% | +43.6% | -35.6% | -19.8% | +242.8% | +41.8% | -76.4% | +7.6% | – | |
| – | +8.6% | +10.5% | +13.4% | +0.5% | +0.9% | -3.3% | -8.1% | -17.0% | -443.8% | – | +0.0% | – | |
| – | – | – | – | – | – | -2,659.0% | – | – | +381.5% | -88.5% | -200.0% | – | |
| – | +32.3% | -9.4% | +13.4% | +0.5% | +0.9% | -3.3% | -8.1% | -17.0% | -18.6% | +32.5% | -92.0% | – | |
| – | +1.0% | +20.1% | -24.7% | +13.6% | -3.5% | +38.6% | -24.9% | -3.8% | +54.7% | +66.0% | -38.8% | – | |
| – | +73.2% | -30.0% | -24.7% | +13.6% | -3.5% | +38.6% | -24.9% | -3.8% | +1,362.8% | -60.1% | -42.9% | – | |
| – | – | – | – | – | – | – | – | – | +92.8% | -151.8% | – | – | |
| – | +11.9% | +27.4% | +73.4% | +40.7% | +12.9% | +3.8% | +8.6% | +14.8% | -12.5% | +5.8% | -2.5% | – | |
| – | – | – | – | – | – | – | – | – | +228.8% | -206.3% | – | – | |
| – | -100.1% | – | -98.4% | -6,722.2% | – | – | -11.4% | – | – | -50.6% | -453,827.5% | – | |
| – | – | – | – | – | – | – | – | – | +228.3% | -206.6% | – | – | |
| – | – | – | – | – | – | – | – | – | +83.1% | -144.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.